Rocky Mountain MS Clinic and Research Group Publications and Presentations

Emerging Data in Treatment-Associated PML

John F. Foley

Clinical Reviews of JCV and PML, A Supplement to Neurology Reviews

Dec 1, 2011, S15-S20

An active effort is under way to further define risk stratification factors that may reduce the risk of PML. Enhanced clinical vigilance and the identification of factors associated with improved prognosis may improve outcomes. 

Multiple Sclerosis Journal

Frost RL, MJ; Foley, JF; Hopkins, MO

Sep 30, 2011, EEG Peak Alpha Frequency and Cognitive Performance in Patients with Multiple Sclerosis


Vermersch P, Kappos L, Gold R

Sep 30, 2011, Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

Clinical Review of JCV and PML, Supplement to Neurological Reviews

Foley J

Sep 29, 2011, The Epidemiology of Progressive Multifocal Leukoencephalopathy